Different batches of the Pfizer-BioNTech COVID-19 vaccine distributed in the U.S. had very different rates of serious adverse events, according to a peer-reviewed research letter.
Let it be known the Denmark team has refused to share the raw data with vaersaware.com because as I'm told, we are not scientists? I don't think anybody has done more analysis on hot/placebo lots the me! Not just creating custom interactive dashboards, but also compiling the most complete list lot number expiration dates in the world!
For some reason nobody wants to mention the "throttling" aka purposeful delay in publication of reports in these pharmacofraudulance systems (VAERS, EMA, MHRA, TGA, etc.). Just the factoid that the Denmark raw data doubled from original version 1 to the updated version 2 Denmark/Sweden study bares out this fact! How many DEATHS are in VAERS from the "harmless" yellow batches? 89 deaths against all countries, but at least 7 deaths coming directly from Denmark!! How is this arbitrary group of 18 yellow batches from Denmark considered "harmless, placebo, or saline"? It's throttling!! Many of those yellow batches still had valid expiration dates and were still being injected into the arms when the snapshot of data saw obtained by the Denmark team.
Like me or not, I could add value to this whole discussion with just a little collaboration from Vibeke and that small crew. You want to talk placebo/harmless lots? Let's talk about ~50 Moderna lot number and verifiable expiration dates (expired) I have with "0" zero VAERS reports in the system. I have more like ~200 lot numbers with 0 VAERS reports, but I'm just talking about lot# where the expiration date has already EXPIRED & 0 REPORTS in VAERS!!!! Somebody needs to let the caged eagle out the cage. God Bless
Well said Albert. The article by Jablonowski and Hooker is sadly deficient. It fails to mention production in bacteria where Pfizer admitted after getting EUA that it has no control batch-to-batch over Endotoxin and its Lipid A. Fails to mention the switch in formula without trial to Tromethamine buffer and fails to mention overseas reports.
Thank you for this. I have been saying forever that if these injections/shots (pussy Englishcucks say "jab") were uniformly solutioned we'd be seeing more adverse reactions and death. I had surmised that many shots were likely placebo and this would explain my contention. You have done us a great service Dr. Baletti
So how do "hot lots" factor into PREP Act liability protection? The notion of hot lots can protect the product overall using the presumption that flaws in specific batches could be solely responsible for serious adverse events/deaths. But in that case, would injuries from those batches still be subject to liability protection? If so, wouldn't that allow manufacturers the ability to experiment on the public with variations in formula/manufacturing practices without recourse?
"A Michigan man, Daniel Nowacki, who received five doses of remdesivir between Nov. 10-24, 2021 — including from the lots that were later recalled — sued Gilead, alleging the contaminated lots caused two strokes and a leg amputation, leaving Nowacki unable to care for himself.
Gilead sought to have the case dismissed, claiming the company was protected under the Public Readiness and Emergency Preparedness (PREP) Act, because remdesivir was under emergency use authorization (EUA) when it was administered to Nowacki.
However, in a July 20, 2023 ruling, Judge Carol Kuhnke of the Circuit Court for the County of Washtenaw rejected Gilead’s motion to dismiss. Kuhnke said that the PREP Act doesn’t extend to issues like contamination for EUA products.
Not a word on the military nature of the toxic CV19 injectables and Craig Paardekooper's great "how bad is my batch" website in the article.
David Hughes, in his extremely well written recent "Covid-19,” Psychological Operations, and the War for Technocracy" book, writes the following on the complete omission of GMP / Good Medical Practices standard that normally applies for pharmaceutical products:
"How was it possible to manufacture billions of doses within such a short time frame? In Latypova’s (2022a, 45:35) assessment, the pharmaceutical companies lacked the required capacity to achieve this, and it was only possible because of the “established defence contracting infrastructure” put in place by BARDA years earlier. A slide on “OWS/BARDA Vaccine Manufacturing” from a presentation by the HHS Administration for Strategic Preparedness and Response divides the manufacturing “portfolio” into two: “vaccines” on the left and “vaccine supporting efforts” on the right (Latypova, 2022a, 44:50). Under “vaccines” fall the various manufacturers, while on the right are Marathon Medical, Emergent Biosolutions, Smiths Medical, Cytiva, BD, Corning, Grand River, Ology, Retractable Technologel Inc., SiO2, The Texas A&M University System, and Snapdragon. All the “vaccine” manufacturers except for Moderna are marked as “Demo,” whereas nearly all of the “vaccine supporting efforts” are marked as “manufacturing” and/or “capacity.”238 D. A. HUGHES Latypova (2022b) proposes that “Demo” refers to Other Transaction Authority, a method of contracting favoured by the DoD, which allows vaguely defined “prototypes” or “demonstrations” to evade regulatory scrutiny. The real manufacturing/capacity-building, she proposes, has been done elsewhere, with Big Pharma content to make vast profits, with freedom from liability (Health & Human Services Department, 2020), in exchange for maintaining the charade that a “public health” crisis is being met with “pharmaceutical” products.
The “Covid-19 vaccines” in the United States do not meet any normal pharmaceutical distribution rules for flagging safety and quality issues in the supply chain (Latypova, 2022b). Unit doses are not barcoded and traceable, and alleged cold chain storage requirements mean that they are handled through a “black box” DoD distribution system. Most suspiciously, Latypova adds, “Independent testing of the vials for verification of the product conformity to label is prohibited”—unsurprisingly, given what they have been shown to contain (Hughes, 2022c)
And, on page 243 in chapter 6 "Weaponized Deception", of the same publication:
....
"Because of the known variability between batches, failure to find mRNA in some vials by no means precludes the possibility that it will be found in others. Yet, one batch in every 200 is over 50 times more deadly than the rest (Hill, 2022; Wilson, 2022; cf. Schmeling et al., 2023), which is too radical a discrepancy to be attributed to bad manufacturing processes, as per D4CE’s (2023, p. 1) analysis. It seems likely that we are dealing here with a worldwide experiment without informed consent, in which certain batches were more toxic than others by design, perhaps to calibrate the tolerance of different groups of people to different levels of whatever is in the shots. At any rate, the deaths of “bad batch” victims cannot be attributed to a general theory of mRNA toxicity."
Not accidental....intentional...with malicious forethought. We have a name for that... MURDER.
Let it be known the Denmark team has refused to share the raw data with vaersaware.com because as I'm told, we are not scientists? I don't think anybody has done more analysis on hot/placebo lots the me! Not just creating custom interactive dashboards, but also compiling the most complete list lot number expiration dates in the world!
https://www.vaersaware.com/siriican-s-moderna-lotsdosdata
https://www.vaersaware.com/siriican-s-pfizer-lots
https://www.vaersaware.com/czechrepublic
For some reason nobody wants to mention the "throttling" aka purposeful delay in publication of reports in these pharmacofraudulance systems (VAERS, EMA, MHRA, TGA, etc.). Just the factoid that the Denmark raw data doubled from original version 1 to the updated version 2 Denmark/Sweden study bares out this fact! How many DEATHS are in VAERS from the "harmless" yellow batches? 89 deaths against all countries, but at least 7 deaths coming directly from Denmark!! How is this arbitrary group of 18 yellow batches from Denmark considered "harmless, placebo, or saline"? It's throttling!! Many of those yellow batches still had valid expiration dates and were still being injected into the arms when the snapshot of data saw obtained by the Denmark team.
Like me or not, I could add value to this whole discussion with just a little collaboration from Vibeke and that small crew. You want to talk placebo/harmless lots? Let's talk about ~50 Moderna lot number and verifiable expiration dates (expired) I have with "0" zero VAERS reports in the system. I have more like ~200 lot numbers with 0 VAERS reports, but I'm just talking about lot# where the expiration date has already EXPIRED & 0 REPORTS in VAERS!!!! Somebody needs to let the caged eagle out the cage. God Bless
https://welcometheeagle.substack.com/
Well said Albert. The article by Jablonowski and Hooker is sadly deficient. It fails to mention production in bacteria where Pfizer admitted after getting EUA that it has no control batch-to-batch over Endotoxin and its Lipid A. Fails to mention the switch in formula without trial to Tromethamine buffer and fails to mention overseas reports.
https://geoffpain.substack.com/p/urgent-please-remove-all-reference
I wonder how much effort it would be to eventually prepare a timeline of AVAILABILITY (first to last/expiry date) of placebo shots by country/region.
Were politicians and influencers partaking in the shots during periods of placebo circulation?
Thank you for your service.
VA still offering the covid DeathVax to veterans with an "additional dose" to veterans 65 years and older.
Thank you for this. I have been saying forever that if these injections/shots (pussy Englishcucks say "jab") were uniformly solutioned we'd be seeing more adverse reactions and death. I had surmised that many shots were likely placebo and this would explain my contention. You have done us a great service Dr. Baletti
So how do "hot lots" factor into PREP Act liability protection? The notion of hot lots can protect the product overall using the presumption that flaws in specific batches could be solely responsible for serious adverse events/deaths. But in that case, would injuries from those batches still be subject to liability protection? If so, wouldn't that allow manufacturers the ability to experiment on the public with variations in formula/manufacturing practices without recourse?
This question comes up for me subsequent to the Remdesivir recall. https://tdefender.substack.com/p/remdesivir-recall-glass-particles-covid-hospital-protoco
"A Michigan man, Daniel Nowacki, who received five doses of remdesivir between Nov. 10-24, 2021 — including from the lots that were later recalled — sued Gilead, alleging the contaminated lots caused two strokes and a leg amputation, leaving Nowacki unable to care for himself.
Gilead sought to have the case dismissed, claiming the company was protected under the Public Readiness and Emergency Preparedness (PREP) Act, because remdesivir was under emergency use authorization (EUA) when it was administered to Nowacki.
However, in a July 20, 2023 ruling, Judge Carol Kuhnke of the Circuit Court for the County of Washtenaw rejected Gilead’s motion to dismiss. Kuhnke said that the PREP Act doesn’t extend to issues like contamination for EUA products.
The case is proceeding through the courts."
Gilead tests for Endotoxin in Remdesivir, but so far I have not found any reported levels.
https://geoffpain.substack.com/p/remdesivir-deaths-was-endotoxin-a
Not a word on the military nature of the toxic CV19 injectables and Craig Paardekooper's great "how bad is my batch" website in the article.
David Hughes, in his extremely well written recent "Covid-19,” Psychological Operations, and the War for Technocracy" book, writes the following on the complete omission of GMP / Good Medical Practices standard that normally applies for pharmaceutical products:
"How was it possible to manufacture billions of doses within such a short time frame? In Latypova’s (2022a, 45:35) assessment, the pharmaceutical companies lacked the required capacity to achieve this, and it was only possible because of the “established defence contracting infrastructure” put in place by BARDA years earlier. A slide on “OWS/BARDA Vaccine Manufacturing” from a presentation by the HHS Administration for Strategic Preparedness and Response divides the manufacturing “portfolio” into two: “vaccines” on the left and “vaccine supporting efforts” on the right (Latypova, 2022a, 44:50). Under “vaccines” fall the various manufacturers, while on the right are Marathon Medical, Emergent Biosolutions, Smiths Medical, Cytiva, BD, Corning, Grand River, Ology, Retractable Technologel Inc., SiO2, The Texas A&M University System, and Snapdragon. All the “vaccine” manufacturers except for Moderna are marked as “Demo,” whereas nearly all of the “vaccine supporting efforts” are marked as “manufacturing” and/or “capacity.”238 D. A. HUGHES Latypova (2022b) proposes that “Demo” refers to Other Transaction Authority, a method of contracting favoured by the DoD, which allows vaguely defined “prototypes” or “demonstrations” to evade regulatory scrutiny. The real manufacturing/capacity-building, she proposes, has been done elsewhere, with Big Pharma content to make vast profits, with freedom from liability (Health & Human Services Department, 2020), in exchange for maintaining the charade that a “public health” crisis is being met with “pharmaceutical” products.
The “Covid-19 vaccines” in the United States do not meet any normal pharmaceutical distribution rules for flagging safety and quality issues in the supply chain (Latypova, 2022b). Unit doses are not barcoded and traceable, and alleged cold chain storage requirements mean that they are handled through a “black box” DoD distribution system. Most suspiciously, Latypova adds, “Independent testing of the vials for verification of the product conformity to label is prohibited”—unsurprisingly, given what they have been shown to contain (Hughes, 2022c)
https://link.springer.com/book/10.1007/978-3-031-41850-1
God Bless Craig Paardekooper, but my toxic lot look-up is much more complete for multiple reasons. vaersaware.com
And, on page 243 in chapter 6 "Weaponized Deception", of the same publication:
....
"Because of the known variability between batches, failure to find mRNA in some vials by no means precludes the possibility that it will be found in others. Yet, one batch in every 200 is over 50 times more deadly than the rest (Hill, 2022; Wilson, 2022; cf. Schmeling et al., 2023), which is too radical a discrepancy to be attributed to bad manufacturing processes, as per D4CE’s (2023, p. 1) analysis. It seems likely that we are dealing here with a worldwide experiment without informed consent, in which certain batches were more toxic than others by design, perhaps to calibrate the tolerance of different groups of people to different levels of whatever is in the shots. At any rate, the deaths of “bad batch” victims cannot be attributed to a general theory of mRNA toxicity."